Increasing incidence of Clostridium difficile infections: Results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population

Epidemiology and Infection

Volumn 144, Issue 12, 2016, Pages 2517-2526

  Alicino, C ^a   Giacobbe, D R ^a,b   Durando, P ^a,b   Bellina, D ^b   Di Bella, A M ^b   Paganino, C ^a   Del Bono, V ^b   Viscoli, C ^a,b   Icardi, G ^a,b   Orsi, A ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Clostridium difficile; healthcare associated infections; hospital acquired infections; incidence; mortality

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CREATININE; HISTAMINE H2 RECEPTOR ANTAGONIST;

AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; ITALY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROTECTION; RETROSPECTIVE STUDY; RISK FACTOR; TEACHING HOSPITAL; AGE; CLOSTRIDIUM INFECTIONS; MICROBIOLOGY; MULTIVARIATE ANALYSIS; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; INCIDENCE; ITALY; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84969677180     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268816000935     Document Type: Article

References (27)

1. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nature Reviews Microbiology 2009; 7: 526-536.
2. Freeman J, et al. The changing epidemiology of Clostridium difficile infections. Clinical Microbiology Reviews 2010; 23: 529-549.
3. Johnson S. Changing epidemiology of Clostridium difficile and emergence of new virulent strains. Clinical Infectious Diseases 2014; 58: 1731-1733.
4. Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clinical Infectious Diseases 2012; 55: s65-70.
5. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US shortstay hospitals, 1996-2003. Emerging Infectious Diseases 2006; 12: 409-115.
6. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and casefatality rate, United States, 2000-2005. Emerging Infectious Diseases 2008; 14: 929-931.
7. Asensio A, et al. Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007. Eurosurveillance 2008; 13: 18943.
8. Bauer MP, et al. Clostridium difficile infection in Europe: A hospital-based survey. Lancet 2011; 377: 63-73.
9. Burckhardt F, et al. Clostridium difficile surveillance trends, Saxony, Germany. Emerging Infectious Diseases 2008; 14: 691-692.
10. McDonald LC, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. New England Journal of Medicine 2005; 353: 2433-2441.
11. Loo VG, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. New England Journal of Medicine 2005; 353: 2442-2449.
12. Kuijper EJ, et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerging Infectious Diseases 2006; 12: 827-830.
13. National Institute of Statistics (Istituto Nazionale di Statistica, ISTAT). 'Noi Italia. 100 statistics to understand the country we live in' (http://noi-italia2015.istat. it/index.php?id=6&user-100ind-pi1%5 Buid-categoria% 5D=03&L=0&cHash=a887dc686dbc48407e54196f84eb 2ede). Accessed 19 April 2016.
14. Centers for Disease Control and Prevention. National Health Safety Network multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) module (http://www.cdc.gov/nhsn/PDFs/pscManual/12psc MDRO-CDADcurrent.pdf). Accessed 19 April 2016.
15. Sailhamer EA, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Archives of Surgery 2009; 144: 433-439.
16. Debast SB, BauerMP, Kuijper EJ. Committee. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): update of the treatment guidance document for Clostridium difficile infection (CDI). Clinical Microbiology and Infection 2013; 20 (Suppl. 2): 1-26.
17. Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373-383.
18. European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals-protocol version 4.3. Stockholm: ECDC; 2012 (http://ecdc.europa.eu/en/publications/Publications/0512-TED-PPS-HAI-antimicrobial-use-protocol.pdf). Accessed 19 April 2016.
19. Di Bella S, et al. Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011. BMC Infectious Diseases 2013; 13: 146.
20. Bassetti M, et al. Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital. Journal of Gastrointestinal and Liver Disease 2014; 23: 459-460.
21. Evans CT, Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clinical Infectious Diseases 2015; 60: S66-71.
22. Honda H, et al. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center. Anaerobe 2014; 25: 5-10.
23. Rodríguez-Pardo D, et al. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. Journal of Clinical Microbiology 2013; 51: 1465-1473.
24. Abou Chakra CN, et al. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: A systematic review. PLoS ONE 2014; 9: e98400.
25. Di Bella S, et al. The protective role of albumin in Clostridium difficile infection: A step toward solving the puzzle. Infection Control and Hospital Epidemiology 2015; 36: 1478-1479.
26. Eliakim-Raz N, et al. Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: A retrospective, case-control study. European Journal of Clinical Microbiology and Infectious Diseases 2015; 34: 1201-1205.
27. Wenisch JM, et al. Hospital-acquired Clostridium difficile infection: determinants for severe disease. European Journal of Clinical Microbiology and Infectious Diseases 2012; 31: 1923-1930.